Medicine guide
LITFULO 50 mg
As listed in the register: LITFULO 50 mg, gélule
· gélule
- Prescription only
- Active substance
- Tosylate De Ritlécitinib
- Made by
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | PFIZER EUROPE MA EEIG (BELGIQUE) |
|---|---|
| Active substance | Tosylate De Ritlécitinib |
| Form | gélule |
| Route | orale |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services PEDIATRIE · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1755 |
| Name in the register | LITFULO 50 mg, gélule |
| Packs | plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s) |
| CIS | 62624259 |
| CIP13 | 3400930279724 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).